Myasthenia Gravis Foundation Of America Inc is located in Westborough, MA. The organization was established in 1954. As of 12/2022, Myasthenia Gravis Foundation Of America Inc employed 11 individuals. This organization is a parent organization of an affiliated group for tax-exemption purposes. Myasthenia Gravis Foundation Of America Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2022, Myasthenia Gravis Foundation Of America Inc generated $4.4m in total revenue. This represents relatively stable growth, over the past 7 years the organization has increased revenue by an average of 5.6% each year. All expenses for the organization totaled $3.8m during the year ending 12/2022. While expenses have increased by 10.2% per year over the past 7 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Since 2016, Myasthenia Gravis Foundation Of America Inc has awarded 34 individual grants totaling $2,698,185. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2022
Describe the Organization's Mission:
Part 3 - Line 1
COMMITTED TO FINDING A CURE FOR MYASTHENIA GRAVIS AND CLOSELY RELATED DISORDERS, IMPROVING TREATMENT OPTIONS, AND PROVIDING INFORMATION AND SUPPORT TO PEOPLE WITH MYASTHENIA GRAVIS THROUGH RESEARCH, EDUCATION, COMMUNITY PROGRAMS AND ADVOCACY.
Describe the Organization's Program Activity:
Part 3 - Line 4a
EVALUATING, FUNDING, AND DISSEMINATING CRITICAL RESEARCH: FUNDING OF HIGH IMPACT MG RESEARCH AT PROMINENT UNIVERSITIES AND MEDICAL INSTITUTIONS, INCLUDING LEVERAGING FUNDS IN COLLABORATION WITH STRATEGIC PARTNERS, SUCH AS THE AMERICAN BRAIN FOUNDATION AND MGNET, TO BRING NEW SCIENTISTS TO MG RESEARCH THROUGH FELLOWSHIPS, FUNDING PILOT GRANTS AND SPECIAL PROJECTS. MGFA MAINTAINS THE ONLY GLOBAL MG PATIENT REGISTRY, WHICH HAS GROWN TO INCLUDE NEARLY 3,500 PARTICIPANTS. MGFA SPONSORS AN ANNUAL SCIENTIFIC SESSION IN CONJUNCTION WITH AANEM, ATTRACTING OVER 250 ATTENDEES. MGFA SPONSORS AN INTERNATIONAL CONFERENCE EVERY 3 YEARS WHICH ATTRACTS LEADING MG RESEARCHERS FROM ALL OVER THE WORLD, ATTRACTING OVER 350 ATTENDEES. MGFA PROVIDES INFORMATION TO 40,000 PLUS CONSTITUENTS ABOUT RESEARCH INITIATIVES AND PROGRESS WHEN APPROPRIATE.
AWARENESS AND ADVOCACY: MGFA PROVIDES OVER 20 EDUCATIONAL BROCHURES ON TOPICS IMPORTANT TO PEOPLE LIVING WITH MG, FREE OF CHARGE TO PATIENTS AND THE PUBLIC. IN ADDITION, MGFA PROVIDES A PROFESSIONAL MANUAL, AND OTHER IMPORTANT EDUCATIONAL INFORMATION, FOR HEALTH CARE PROFESSIONALS. THE MGFA CONDUCTS AN ANNUAL AWARENESS CAMPAIGN, JUNE MG AWARENESS MONTH, REACHING OUT THROUGH OUR SUPPORT GROUPS, AN AWARENESS TOOLKIT FOR ALL WHO ARE INTERESTED IN RAISING AWARENESS OF MG IN THEIR COMMUNITIES, PRESS RELEASES, POSTERS AND PROMOTION IN SOCIAL MEDIA. MGFA ANNUALLY HOSTS A NATIONAL PATIENT CONFERENCE, A GATHERING OF THE MG COMMUNITY WHICH FEATURES MG RESEARCH UPDATES, PATIENT STORIES, NEWS ABOUT MG TREATMENTS AND DISCOVERIES AND MANY EXCITING EDUCATIONAL TOPICS TO HELP PATIENTS AND CAREGIVERS MANAGE THEIR MG JOURNEY. MGFA HAS ALSO DEVELOPED AN ONLINE COMMUNITY PLATFORM WHICH IS A ONE-OF-A-KIND VIRTUAL NEIGHBORHOOD WHERE THE MG COMMUNITY CAN CONNECT, SHARE IDEAS AND DISCOVERIES AND ACCESS MG-SPECIFIC EDUCATIONAL MATERIALS SUCH AS LIVE BROADCASTS, WEBINARS AND INFORMATION LIBRARIES IN ONE PLACE. MGFA ALSO MAINTAINS AN EXTENSIVE WEBSITE WHICH PROVIDES PATIENTS AND CAREGIVERS WITH EDUCATIONAL CONTENT AND NEWS AS WELL AS FACEBOOK PAGE TO PROMOTE AWARENESS AND THE ORGANIZATION'S EDUCATIONAL MISSION.
INFORMATION, EDUCATION AND SUPPORT: MGFA PROVIDES MATERIAL, INFORMATION AND REFERRAL, AND EDUCATION AND SUPPORT PROGRAMS TO HELP PEOPLE MANAGE THE CHALLENGES OF LIVING WITH MYASTHENIA GRAVIS. MGFA IS A NATIONAL ORGANIZATION THAT SUPPORTS THE DELIVERY OF PROGRAMS AND SERVICES THROUGH A MYRIAD OF CHANNELS INCLUDING A NETWORK OF APPROXIMATELY 85 SUPPORT GROUPS, PARTNERS IN MG CARE AND A NUMBER OF OTHER NETWORKS NATIONWIDE. THE MGFA WEBSITE IS ONE OF THE ORGANIZATION'S GREATEST RESOURCES AND IS A PREMIER SOURCE OF INFORMATION. MGFA ALSO HOSTS A NUMBER OF LIVE AND INTERACTIVE EDUCATIONAL FORUMS, INCLUDING 18 WELLNESS AND RESEARCH WEBINARS AS WELL AS HOSTED FIVE COMMUNITY HEALTH FAIRS IN VARIOUS US CITIES FOR MG PATIENTS AND CAREGIVERS TO INTERACT, OBTAIN INFORMATION AND LEARN ABOUT MG RESEARCH AND TREATMENT DEVELOPMENTS FROM MG EXPERTS AND CORPORATE INDUSTRY LEADERS.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Brian Gladden Chair | OfficerTrustee | 8 | $0 |
William Sauerwine Vice Chair | OfficerTrustee | 8 | $0 |
Michael Lifshitz Secretary | OfficerTrustee | 8 | $0 |
Justin Stachtiaris Treasurer | OfficerTrustee | 4 | $0 |
Adrejia Boutte Director (started 07/2022) | Trustee | 4 | $0 |
Richard J Nowak MD Director (started 07/2022) | Trustee | 4 | $0 |
Vendor Name (Service) | Service Year | Compensation |
---|---|---|
Kellen Company Program Staffing | 12/30/20 | $187,500 |
Mueller & Co Llp Financial Management | 12/30/20 | $182,323 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $58,781 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $3,550,106 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $3,608,887 |
Total Program Service Revenue | $452,123 |
Investment income | $252,442 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $22,837 |
Net Income from Fundraising Events | $48,294 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $4,388,529 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $789,999 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $231,757 |
Compensation of current officers, directors, key employees. | $46,351 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $1,019,696 |
Pension plan accruals and contributions | $11,704 |
Other employee benefits | $951 |
Payroll taxes | $88,600 |
Fees for services: Management | $0 |
Fees for services: Legal | $0 |
Fees for services: Accounting | $14,259 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $94,714 |
Fees for services: Other | $205,979 |
Advertising and promotion | $55,427 |
Office expenses | $155,680 |
Information technology | $129,036 |
Royalties | $0 |
Occupancy | $0 |
Travel | $58,586 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $518,311 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $23,913 |
Insurance | $22,275 |
All other expenses | $0 |
Total functional expenses | $3,790,735 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $1,069,936 |
Savings and temporary cash investments | $0 |
Pledges and grants receivable | $173,000 |
Accounts receivable, net | $192,976 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $152,115 |
Net Land, buildings, and equipment | $113,510 |
Investments—publicly traded securities | $9,662,414 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $0 |
Total assets | $11,363,951 |
Accounts payable and accrued expenses | $331,083 |
Grants payable | $784,166 |
Deferred revenue | $155,879 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $60,000 |
Total liabilities | $1,331,128 |
Net assets without donor restrictions | $5,381,564 |
Net assets with donor restrictions | $4,651,259 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $11,363,951 |
Over the last fiscal year, Myasthenia Gravis Foundation Of America Inc has awarded $789,999 in support to 5 organizations.
Grant Recipient | Amount |
---|---|
UNIVERSITY OF PENNSYLVANNIA PURPOSE: Preclinical models and biomarkers for predicting MuSK-CAART clinical outcomes | $300,000 |
THE GEORGE WASHINGTON UNIVERSITY PURPOSE: Dr Kaminski's MG Net Pilot Studies program | $50,000 |
YALE UNIVERSITY PURPOSE: Measuring AChR autoantibody effector functions in myasthenia gravis patients. | $225,000 |
UNIVERSITY OF MICHIGAN PURPOSE: Advancing patient-centered care and research for ocular myasthenia gravis: Validation of a novel patient reported outcome measure | $55,000 |
AMERICAN BRAIN FOUNDATION PURPOSE: Medical research | $159,999 |